Each year, various staff in the Epidemiology and Genomics Research Program (EGRP) nominate and vote for manuscripts published by EGRP grantees. These manuscripts are deemed to have the greatest potential scientific and/or public health impact. Dr. Rajen Mody’s manuscript, Integrative Clinical Sequencing in the Management of Refractory or Relapsed Cancer in Youth, was selected as one of EGRP’s 2015 research highlights. It reported on the first 102 patients enrolled in the PedsMiOncoSeq program, which includes sequencing the tumor’s DNA and RNA as well as normal DNA from children and young adults with cancer that has relapsed or that is rare. Congratulations on the recognition, Dr. Mody!
February 24, 2016
